Press release
Radiopharmaceuticals CDMO/CMO Services Market Advanced Market Intelligence Report 2026 to 2035
Get Free Sample Report
https://www.insightaceanalytic.com/request-sample/2472
Radiopharmaceuticals CDMO/CMO Services are providing regulatory guidance and streamlining the manufacturing process. Due to growing concerns over the rapid increase in cancer patients, the adoption of Radiopharmaceuticals CDMO/CMO Services is expected to increase in the coming years. The rising therapeutic applications and increasing share of pipeline molecules are among the other factors expected to boost the growth of the global Radiopharmaceuticals CDMO/CMO Services market.
Moreover, shifting consumer preference towards generic medicines and biologics, coupled with high disposable income, are factors expected to create potential revenue opportunities for players operating in the global Radiopharmaceuticals CDMO/CMO Services market. High investments by major players and new advancements for the development of various end-use products have created lucrative revenue opportunities for major manufacturers and suppliers of the Radiopharmaceuticals CDMO/CMO Services. Favorable government initiatives to promote the use of Radiopharmaceuticals CDMO/CMO Services owing to environmental and patient concerns are expected to support the growth of the target market.
List of Prominent Players in the Radiopharmaceuticals CDMO/CMO Services Market:
• Minerva Imaging
• Evergreen Theragnostics, Inc.
• NMR
• PharmaLogic
• Eckert & Ziegler
• AtomVie
• Eczacibasi-Monrol
• Cardinal Health
• Nucleus Radiopharma
• Seibersdorf Labor GmbH
• Siemens Healthineers
• SOFIE
• SpectrumRx
• Agilera Pharma AS
• Grupo RPH
Market Dynamics:
Drivers-
Growing investment in the biotechnology and pharmaceutical industries is a key factor expected to drive growth of the target market. The rising number of biologics products anticipated to be launched for Radiopharmaceuticals CDMO/CMO Services is another factor expected to contribute significant revenue share in the global Radiopharmaceuticals CDMO/CMO Services market. Additionally, the rising production capacity for biologics products of various Radiopharmaceuticals CDMO/CMO Services and others is a factor expected to augment the growth of the global Radiopharmaceuticals CDMO/CMO Services market.
Read Report Overview
https://www.insightaceanalytic.com/report/radiopharmaceutical-cdmocmo-services-market/2472
Challenges:
The prime challenge is the lack of awareness and acceptance of Radiopharmaceuticals CDMO/CMO services in developing countries, which is predicted to reduce the growth of the Radiopharmaceuticals CDMO/CMO Services market. However, the high cost of Radiopharmaceuticals CDMO/CMO Services is another factor expected to hamper the overall growth of the Radiopharmaceuticals CDMO/CMO Services market over the coming years. Owing to the COVID-19 pandemic, the number of cases has been increasing, which led to a global or partial shutdown to maintain social distancing.
Regional Trends:
The North American radiopharmaceuticals CDMO/CMO Services market is expected to register a major market share in terms of revenue and is projected to grow at a high CAGR in the near future. Growing chronic diseases such as cancer and heart-related problems coupled with increasing R&D activities by prominent players are factors expected to proliferate the growth of the Radiopharmaceuticals CDMO/CMO Services market in the region.
Besides, Europe had a substantial share in the market due to its developed economy and growing adoption of the product. This is due to the adoption of new strategies by the major players in the Radiopharmaceuticals CDMO/CMO Services market. Moreover, the presence of key market players and increasing collaboration among major players for market penetration in the region provides the opportunity for growth of the global Radiopharmaceuticals CDMO/CMO Services market.
Recent Developments:
• In May 2024, PharmaLogic Holdings Corp., a prominent CDMO (contract development and manufacturing organization) radio pharmacy solutions provider, launched its radiopharmaceutical production and research facility in New York.
Add our site to Google Preferred Sources for quality content : https://google.com/preferences/source?q=insightaceanalytic.com
Segmentation of Radiopharmaceuticals CDMO/CMO Services Market-
By Application-
• Diagnostic Radiopharmaceuticals
• Therapeutic Radiopharmaceuticals
By Type of Radioisotopes-
• Technetium-99m
• Fluorine-18
• Leutetium-177
• Gallium-68
• Actinium-225
• Other Radioisotopes
By Source of Manufacturing-
• Nuclear Reactors
• Cyclotrons
By Scale of Operation-
• Preclinical
• Clinical
• Commercial
By Therapeutic Area-
• Cardiovascular Disorders
• Neurological Disorders
• Oncology
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customization/2472
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Official Site Visit: www.insightaceanalytic.com
Tel.: +1 607 400-7072
Email: info@insightaceanalytic.com
Follow US On :
LinkedIn @ https://www.linkedin.com/company/insightace-analytic-pvt-ltd/
Twitter @ https://x.com/MInsightace
YouTube @ https://www.youtube.com/@InsightAceAnalytic
Instagram @https://www.instagram.com/insight_ace_analytic/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Radiopharmaceuticals CDMO/CMO Services Market Advanced Market Intelligence Report 2026 to 2035 here
News-ID: 4420609 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Regenerative Agriculture Market Revenue Share Analysis and Industry Forecast 202 …
"Regenerative Agriculture Market" in terms of revenue was estimated to be worth $ 11.74 billion in 2024 and is poised to reach $ 49.07 billion by 2034, growing at a CAGR of 15.5% from 2025 to 2034 according to a new report by InsightAce Analytic.
Get Free Sample Report @
https://www.insightaceanalytic.com/request-sample/1623
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing global Regenerative agriculture are:
• The threat of new competitors in the…
Radioligand Therapy Market Size Benchmarking and Outlook 2026 to 2035
The Radioligand Therapy Market Size is valued at USD 2.65 Billion in 2025 and is predicted to reach USD 9.31 Billion by the year 2035 at a 13.5% CAGR during the forecast period for 2026 to 2035.
Global Radioligand Therapy Market 2026-2035 full Research Repot latest version is now available.
Get Free Sample Report
: https://www.insightaceanalytic.com/request-sample/1281
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Radioligand Therapy market are:
• Increasing prevalence of cancer…
Wellness Tourism Market Future Growth Hotspots and Forecast 2026 to 2035
"Wellness Tourism Market" in terms of revenue was estimated to be worth $ 991.7 billion in 2024 and is poised to reach $ 2727.5 billion by 2034, growing at a CAGR of 10.8% from 2025 to 2034 according to a new report by InsightAce Analytic.
Get Free Sample Report @
https://www.insightaceanalytic.com/request-sample/1603
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Wellness Tourism Market are:
• Growing Global Awareness of Health…
Patient Recruitment and Retention Services Market Value Chain and Forecast Analy …
The Patient Recruitment and Retention Services Market Size is valued at USD 4.1 Billion in 2024 and is predicted to reach USD 6.7 Billion by the year 2034 at a 5.3% CAGR during the forecast period for 2025-2034.
Get Free Sample Report:
https://www.insightaceanalytic.com/request-sample/1335
Patient recruitment and retention services involve identifying, enrolling, and maintaining eligible participants in clinical studies through strategic methodologies and technologies. These services play a crucial role in completing the…
More Releases for Radiopharma
Nuclear Pharmacy Market Future Business Opportunities 2025-2032 | Curium Pharma, …
The Latest study titled Nuclear Pharmacy Market 2025, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2025 to 2032. The comprehensive research delves into the evolving market dynamics, value chain analysis, prominent investment areas, competitive landscape, regional outlook, and key market segments. It also offers a thorough assessment of the global market's drivers and constraints. Additionally, the report…
Actinium Pharmaceuticals (ATNM) Garners Attention with Clinical Successes and St …
Actinium's Chief Medical Officer, said, "In addition to demonstrating unprecedented 100% access to BMT in Iomab-B treated patients with active r/r AML and achieving the primary endpoint of dCR with high statistical significance, we are excited by the compelling outcomes in patients with a TP53 mutation in the SIERRA trial. We look forward to returning to EBMT and once again highlighting the positive results from the Phase 3 SIERRA trial…
Actinium Pharmaceuticals (ATNM): A Prime Buyout Candidate Amidst a Radiopharma A …
Biotech Stocks Taking Centerstage
As the pharmaceutical industry ventures deeper into the era of precision medicine, radiopharmaceuticals, particularly those involving alpha emitters like Actinium-225 (Ac-225), are gaining prominence for their targeted approach to cancer treatment. Amid this innovative surge, Actinium Pharmaceuticals (NYSE:ATNM) emerges not just as a company with a promising pipeline but as a beacon of cutting-edge manufacturing capabilities that could very well position it as a prime buyout candidate…
2030 Projections: Radiopharmaceutical Synthesizers Market to Deliver Dynamic Pro …
The Radiopharmaceutical Synthesizers Market Research Report 2023-2030 provides in-depth information on market trends, market capacity, industry size, growth factors, share, innovations, competitive environment, business problems, and more. This report's historical data confirms demand growth on a global, national, and regional scale. The studies on the global industry cover everything from comprehensive research to market size and forecasting to dynamics, growth factors, prospects, and hazards, as well as vendor knowledge. The…
Automated Radiosynthesis Modules Market Strategic Assessment & SWOT Analysis 202 …
An Informative report titled as Global Automated Radiosynthesis Modules Market has recently been published by Report Consultant to its online repository. This statistical data offers an in-depth analysis by considering several segments, such as type, size, technology and applications. Different exploratory techniques such as, qualitative and quantitative analysis have been used to give data accurately. For better understanding of the customers, it uses effective graphical presentation techniques, such as graphs,…
Cyclotron Market Growth Opportunities Analysis Report | GE Healthcare, Siemens H …
Cyclotron Market: Introduction
According to the report, the global cyclotron market was valued at US$ 215.5 Mn in 2019. It is projected to expand at a CAGR of ~3% from 2020 to 2030. Expansion activities of key radiopharma players; applications in clinical trials; increase in the geriatric population; pipeline assessment of new drugs; and disease indication mortality are major factors driving the cyclotron market. The shutdown of a few nuclear reactors has led to the…
